Bioventus Inc. (NASDAQ: BVS) reported Q1 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the quarter came in at $123.9 million versus the consensus estimate of $122.7 million.

For earnings history and earnings-related data on Bioventus Inc. (BVS) click here.